State medication access · Selected providers
Tirzepatide: online access in Maryland.
Company statements checked between September 10, 2026 and September 23, 2026: 3 covered companies — Gentle Health, GoodRx Care and Mochi Health — advertise online access to Tirzepatide for patients in Maryland. Confirm eligibility and total charges with the provider.
Company-reported Maryland access to tirzepatide through Gentle Health's and Mochi Health's compounded programs and GoodRx Care Direct's branded Zepbound KwikPen, with product, first-visit and payment limitations.
Selected product offers advertised for patients in Maryland, not verified local offices, pharmacy stock, appointment slots or prescription guarantees.
Maryland’s product listing and the next steps
One documented offer in Maryland is Gentle Health’s compounded injectable tirzepatide program. Keep that description in view when checking the first review, quoted tier and cancellation terms.
Gentle Health’s compounded preparation is not an approved generic or branded Zepbound or Mounjaro. FDA describes this distinction; an ingredient listing is not an equivalence claim.
The state workflow article, published August 21, lists Maryland as intake-review-first. That leaves the clinician free to seek more information, require live review or decline; it does not promise appointment-free prescribing or establish current law.
Check the price and cancellation terms
Gentle Health advertises compounded injectable tirzepatide at $169, $219 or $269 monthly, without a separate membership fee. Its current terms say the first medication request starts a recurring monthly subscription. Cancellation is available before pharmacy submission or beginning 30 days after the order date once submitted; it stops future billing immediately, but the current billing month’s remainder is not refunded. Pharmacy-stage refunds are handled case by case.
Coverage is not an appointment or stock guarantee. Check fulfillment directly; the Gentle Health profile and national tirzepatide guide explain the broader context.
GoodRx Care Direct: branded Zepbound KwikPen
GoodRx is listed for Zepbound KwikPen, a branded tirzepatide pen rather than a compounded preparation. Its help-center article says GoodRx Care Direct weight loss treatment is available in all U.S. states except Alabama and Louisiana, which includes Maryland; it names the service, not individual drugs. The Zepbound KwikPen page advertises $299 a month as an introductory price limited to one KwikPen strength it labels 10 mg, plus a separate $39 monthly membership that excludes medication. The same page also cites “as low as $149 for medication” and $995 a month for standard pens, unreconciled. Enrolment does not establish a prescription, dose or pharmacy stock. See the GoodRx Care profile.
Mochi Health: compounded tirzepatide
Mochi is listed for compounded tirzepatide, which is not FDA-approved and is distinct from branded Zepbound. Mochi’s Maryland page names compounded semaglutide and tirzepatide among the medications its providers may prescribe there. Its August pricing guide lists compounded tirzepatide at $90–199 per month, depending on prescription, state and pharmacy. Membership is billed separately: an eligible new-member offer of $39 for the first month, which Mochi says is not available in all states, then $79 monthly. The state page does not establish pharmacy stock, individual eligibility or the price in Maryland. See the Mochi Health profile.
Compare prices
All-in cost for the first 12 weeks at each covered provider, including membership and medication fees, commitments and renewal terms.
More guides for patients in Maryland
Related
Other care areas
- Chronic care
- Dermatology
- Fertility
- Hair loss
- Hormone health
- Men's health
- Mental health
- Pediatrics
- Primary care
- Sexual health
- Urgent care
- Women's health
Other medications
More telehealth providers in Maryland
Browse the complete Inside Telehealth directory for Maryland, combining the care and medication guides currently supported by our state-level evidence.
City listings
The same statewide online access, listed for readers in these cities. This is not a map of local offices.
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| Gentle Health | Compounded injectable tirzepatide | $169/mo advertised monthly bundle, Compounded injectable tirzepatide | Official site ↗ | |
| GoodRx Care | Zepbound KwikPen | $338/mo partial monthly subtotal, Zepbound KwikPen | Official site ↗ | |
| Mochi Health | Compounded tirzepatide | $169/mo partial monthly subtotal, Compounded tirzepatide | Official site ↗ |
Selected providers
Which providers offer Tirzepatide in Maryland?
3 companies with published profiles and service-specific source records. Listed alphabetically, not ranked. This is selected coverage—not every provider in the market.
Formats describe the program, not a guaranteed first-visit option in every state. A messaging or questionnaire option does not promise an initial evaluation without a live appointment. Read each provider’s service and state access notes.
The monthly cost column adds disclosed medication and required membership charges at each advertised dose and labels each figure an advertised bundle or a known subtotal. Where labs, taxes or other charges are not priced, the figure is not a guaranteed final bill. Cash prices use each provider’s stated monthly billing basis; supplied weeks and upfront commitments can differ. Dose labels identify price tiers, not treatment recommendations.
| Company & service | Program formats & clinicians | Payment & advertised charges | Monthly cost by dose | Access & evidence |
|---|---|---|---|---|
| Gentle Health Gentle Health's compounded injectable tirzepatide program, if prescribed, billed through its medication-order subscription.
Medical Director: James Simmons, MD — company-reported; see profile for the source. |
Gentle Health describes physician evaluation with online intake and live-visit arrangements. A coverage listing does not establish approval, an appointment slot or pharmacy stock. Access channel: Direct to consumer | Cash pay Advertised monthly tirzepatide tiers are $169, $219 and $269, without a separate membership charge. Current terms allow cancellation before pharmacy submission or beginning 30 days after the order date once submitted. | Compounded injectable tirzepatide · injection Advertised monthly bundle
Medication, physician reviews, messaging/video visits and delivery; the company advertises no membership fee or added tax. Not priced: Patient-specific laboratory testing is not priced on the reviewed pages. Billing and introductory offersMonthly subscription price. Current terms allow cancellation before pharmacy submission or beginning 30 days after the order date once submitted; cancellation stops future billing without refunding the current billing month's remainder. Price check: . Gentle Health — services, price table and frequently asked questions · Gentle Health — Terms of Service | Compounded injectable tirzepatide — injection: Company-reported Maryland coverage for the named compounded injectable tirzepatide program. The company's workflow article lists Maryland as online-first; a clinician may still request a live visit or decline. Coverage does not establish individual approval, pharmacy eligibility or stock. The company names compounded injectable tirzepatide in the program description for every jurisdiction enumerated on its coverage page, including Maryland. This is an advertised compounded product, not a branded or FDA-approved generic offer. The statement does not independently verify pharmacy dispensing eligibility, current stock, clinician approval, individual eligibility or legal clearance for an order. State evidence checked · Product state availability source This is compounded injectable tirzepatide, not branded Zepbound or Mounjaro. The company's coverage article reports it across 40 states plus DC and names Missouri as the newest addition on September 18. Its Missouri detail page was still being added when rechecked. Individual eligibility and fulfillment remain unverified. Company-reported · Checked
|
| GoodRx Care GoodRx Care Direct's separately priced branded tirzepatide pen, billed apart from its monthly membership fee.
|
GoodRx describes online care from licensed healthcare professionals, with a consultation and ongoing messaging included in the subscription. Its footer states that prescriptions follow only if deemed medically appropriate by the treating healthcare provider; confirm whether the individual consultation is a live visit or an online review. Access channel: Direct to consumer | Cash pay GoodRx advertises Zepbound KwikPens from $299 a month, an introductory price the page limits to a single KwikPen strength it labels 10 mg, plus a separate $39 a month for unlimited online support; the footnotes state the membership fee does not include medication cost. The visible KwikPen offer is $299, but separate embedded content on the same page still cites $995 a month for standard Zepbound pens, plus the same $39 monthly care charge. The page is internally inconsistent, so confirm which Zepbound format is being bought before relying on either figure. A banner on the page also advertises 'as low as $149 for medication'. It says prices vary by pharmacy and location and suggests checking the reader's own plan formulary first. | Zepbound KwikPen · pen Known monthly subtotal—not a confirmed all-in total
Includes the $39/month membership in each figure above. Unlimited online care from licensed healthcare providers under the GoodRx Care Direct membership, billed monthly and separately from the medication. Not priced: The footnotes state the $39 monthly membership fee does not include medication cost. Pharmacy and location price variation, and any laboratory work, are not priced on the page. Billing and introductory offersThe $299 rate is the medication price for the single introductory KwikPen strength and excludes the $39 monthly membership. The page calls that strength its lowest dose while elsewhere describing 10 mg once weekly among the highest maintenance doses, so its own dose labelling is inconsistent. The page's banner separately advertises 'as low as $149 for medication', and embedded content on the same page still quotes $995 a month for standard Zepbound pens; none of these figures is reconciled against the $299 KwikPen price. The page describes $299 as an introductory price limited to one KwikPen strength, which it labels 10 mg. Price check: . GoodRx Care Direct — Get Zepbound KwikPen online | Zepbound KwikPen — pen: GoodRx's help center says GoodRx Care Direct weight loss treatment is available in all U.S. states except Alabama and Louisiana, which includes Maryland; the product pages offer these medications through that service. Enrolment does not establish a prescription, a particular dose or pharmacy fulfilment. GoodRx's help-center article states that GoodRx Care Direct weight loss treatment is available in all U.S. states except Alabama and Louisiana. It names the service, not individual drugs; the Zepbound KwikPen online page offers Zepbound KwikPen through GoodRx Care Direct and states that weight loss treatment via GoodRx Care Direct is not available in Alabama or Louisiana at this time. The District of Columbia is not mentioned and is not included. This does not establish eligibility, a prescription, a particular dose or introductory offer, or pharmacy stock at a given address. State evidence checked · Product state availability source The $299 figure is an introductory, single-dose price and is not the ongoing monthly charge at higher doses. The address advertising a Zepbound vial redirected to this KwikPen page when checked, and no vial offer is recorded here; the KwikPen is described as a multi-dose, single-patient-use pen. GoodRx states on this page that it is not health insurance. Enrolment does not establish a prescription, pharmacy stock or availability at a given address. GoodRx states on this page that weight loss treatment via GoodRx Care Direct is not available in Alabama or Louisiana at this time; that exclusion is specific to this service, not to GoodRx as a company. Company-reported · Checked |
| Mochi Health Compounded tirzepatide orders through Mochi's paid membership route, if prescribed.
|
Mochi describes provider video visits and messaging; confirm the assigned provider's credential and prescription-specific follow-up arrangement. Access channel: Direct to consumer | Cash pay The August pricing guide lists compounded tirzepatide at $90–199 per month, depending on the prescription, state and pharmacy. Paid membership is additional: an eligible new-member offer is $39 for the first month, which the page says is not available in all states, then $79 monthly. Diagnostics are excluded from that membership. The lowest medication rate is not every patient's quote. | Compounded tirzepatide · injection Known monthly subtotal—not a confirmed all-in total
Includes the $79/month membership in each figure above. Compounded injection and monthly membership with provider visits, messaging and coaching. Shipping is advertised included. Not priced: Diagnostic services are excluded. Terms allow applicable taxes and fees; the final pharmacy/state-specific quote may differ. Billing and introductory offersThe source labels its medication price as one monthly vial. These are the company's representative tiers, not dose recommendations or equivalents to branded strengths. Figures use the $79 monthly membership, not a prepaid plan. Eligible new members pay $39 membership for the first month, reducing each subtotal by $40. The offer is not available in every state. Price check: . Mochi Health — New Per-Dose Pricing: What Changed · Mochi Health — services and membership · Mochi Health — FAQ · Mochi Health — Terms of Use, updated July 10, 2026 | Compounded tirzepatide — injection: Mochi's Maryland page names compounded semaglutide and tirzepatide among the medications its providers may prescribe there. It does not establish pharmacy stock, individual eligibility, the price in Maryland or pharmacy fulfilment. Mochi's Maryland state page, answering which weight loss medications it offers there, names compounded semaglutide and tirzepatide among its compounded medication options. This is an advertised compounded product, not a branded or FDA-approved generic offer. The company's medications page separately says availability and pricing vary by state. The page does not establish pharmacy stock, the dispensing pharmacy, clinician approval, individual eligibility, the price in Maryland or legal clearance for an order. State evidence checked · Product state availability source This is a compounded offer, not branded Zepbound or Mounjaro. The published range does not establish stock, pharmacy assignment or eligibility in every state; check the current account quote before ordering. Mochi's FAQ says insurance coverage depends entirely on the individual carrier, plan and employer and describes a separate Wellness Plus plan available with qualifying insurance; the selected offers here are recorded at their advertised cash rates. That is not a finding that Mochi refuses insurance or that a compounded prescription can never be covered. Company-reported · Checked |
No providers match these filters. Try a different payment model or program format.
How companies enter this list
Each listed product has separately reviewed, current product-specific evidence for this state. A company footprint or broad care service cannot establish medication access. Named products, forms and approval categories remain distinct; inclusion is not a claim of interchangeability. The list is selective, not a complete inventory of providers. Inclusion does not establish clinical suitability, state licensure or a currently available appointment.
Smaller and larger providers use the same source requirements and alphabetical ordering. Visit each profile for company history and wider context, or suggest another provider.
Source documents
The table dates show when its claims were checked. Document dates below describe the original sources, where supplied. Additional sources are linked directly in the guide.
- Zepbound — Product labeling on DailyMed — Eli Lilly and Company; hosted by the U.S. National Library of Medicine
- FDA — Concerns with unapproved GLP-1 drugs — U.S. Food and Drug Administration
- FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs — U.S. Food and Drug Administration
- Gentle Health — services, price table and frequently asked questions — Gentle Health
- Gentle Health — states served and expansion account — Gentle Health; published
- Gentle Health — Connecticut GLP-1 weight-loss service page — Gentle Health
- Gentle Health — Vermont GLP-1 weight-loss service page — Gentle Health
- Gentle Health — Terms of Service — Gentle Health
- How Gentle Health's Initial Prescribing Process Varies by State — Gentle Health; published
- GoodRx Care Direct — Get Zepbound KwikPen online — GoodRx
- GoodRx Care — Online care — GoodRx
- GoodRx — Terms of use — GoodRx; revised
- GoodRx Help Center — Where is GoodRx Care Direct Available? (Weight Loss) — GoodRx
- Mochi Health — New Per-Dose Pricing: What Changed — Mochi Health
- Mochi Health — services and membership — Mochi Health
- Mochi Health — FAQ — Mochi Health
- Mochi Health — Maryland Telehealth Platform Online — Mochi Health